If you're in biopharma or allied sectors, the INR 10K Cr Biopharma Shakti isn't just funding; it's...

If you're in biopharma or allied sectors, the INR 10K Cr Biopharma Shakti isn't just funding; it's a strategic pivot. India aims for high-value biologics and advanced manufacturing, moving beyond generics.

This means massive opportunities for CDMOs, specialized R&D, and talent development. Get ready for ecosystem growth.

https://inc42.com/buzz/union-budget-2026-centre-to-launch-biopharma-shakti-with-outlay-of-inr-10k-cr/